Nagisa Morikawa
Kurume, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Management and Outcomes of Acute Coronary Syndrome during and after the COVID-19 Pandemic in Kurume City: A Multicenter Observational Study.
Journal: The Kurume medical journal
Published: August 30, 2026
Extended Anticoagulation Therapy with Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Status of Concomitant Deep Vein Thrombosis: Insights from the ONCO PE Randomized Trial.
Journal: Seminars in thrombosis and hemostasis
Published: August 14, 2026
Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial.
Journal: Thrombosis and haemostasis
Published: May 15, 2026
Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial.
Journal: Journal of the American Heart Association
Published: February 27, 2026
Combined Monocyte Chemoattractant Protein-1 and High-Sensitivity C-Reactive Protein Predict Mortality Rates in the General Population - Evidence From a Community-Based Cohort in Japan.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: February 18, 2026
Circulating Thrombospondin-2 Levels Reflect Hepatic Fibrosis Severity and Renal Dysfunction in a General Population: Uku Study.
Journal: The Kurume medical journal
Published: January 28, 2026
JSH 2025 in global perspective: blood pressure management in HFpEF across major guidelines.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: November 21, 2025
Elevated serum galectin-3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10-year follow-up study.
Journal: Journal of diabetes investigation
Published: November 12, 2025
Reply to: Heart failure with preserved ejection fraction and a systolic blood pressure target of 129 mmHg: are we on cloud nine?
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: September 24, 2025
Serum zinc-α2-glycoprotein and renal dysfunction in the general population: evidence from a 13-year cohort study.
Journal: Clinical and experimental nephrology
Published: September 22, 2025
Systolic blood pressure lower than 130 mmHg in heart failure with preserved ejection fraction: a systematic review and meta-analysis of clinical outcomes.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 12, 2025
Last Updated: 09/26/2026